Related Experiment Video
Updated: Oct 18, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial
Hugo Vrenken1, Mark Jenkinson2, Dzung L Pham2
1From the MS Center Amsterdam (H.V., A.d.S., V.W.), Amsterdam Neuroscience, Department of Radiology and Nuclear Medicine, Amsterdam UMC (M.P.), the Netherlands; Wellcome Centre for Integrative Neuroimaging (WIN), FMRIB (M.J.), Nuffield Department of Clinical Neurosciences (NDCN), University of Oxford, UK; Human Imaging and Image Processing Core (D.L.P.), Center for Neuroscience and Regenerative Medicine, The Henry M. Jackson Foundation, Bethesda, MD; Center for Neurological Imaging (C.R.G.G.), Department of Radiology, Brigham and Women's Hospital, Boston, MA; Section of Neuroradiology (Department of Radiology) (D.P.), Vall d'Hebron University Hospital and Research Institute (VHIR), Autonomous University Barcelona, Spain; Neuroimaging Research Unit (M.A.R.), Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy; AMIGO (M.J.C.), School of Biomedical Engineering and Imaging Sciences, King's College London; and Institutes of Neurology & Healthcare Engineering (F.B.), UCL London, UK. h.vrenken@amsterdamumc.nl.
Abstract:
Patients with multiple sclerosis (MS) have heterogeneous clinical presentations, symptoms, and progression over time, making MS difficult to assess and comprehend in vivo. The combination of large-scale data sharing and artificial intelligence creates new opportunities for monitoring and understanding MS using MRI. First, development of validated MS-specific image analysis methods can be boosted by verified reference, test, and benchmark imaging data. Using detailed expert annotations, artificial intelligence algorithms can be trained on such MS-specific data. Second, understanding disease processes could be greatly advanced through shared data of large MS cohorts with clinical, demographic, and treatment information. Relevant patterns in such data that may be imperceptible to a human observer could be detected through artificial intelligence techniques. This applies from image analysis (lesions, atrophy, or functional network changes) to large multidomain datasets (imaging, cognition, clinical disability, genetics). After reviewing data sharing and artificial intelligence, we highlight 3 areas that offer strong opportunities for making advances in the next few years: crowdsourcing, personal data protection, and organized analysis challenges. Difficulties as well as specific recommendations to overcome them are discussed, in order to best leverage data sharing and artificial intelligence to improve image analysis, imaging, and the understanding of MS.

